Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Biohacking has moved from niche experiments to a global movement reshaping how we think about human potential. With ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Researchers use CRISPR to overcome seemingly insurmontable reproductive barriers — but that doesn't mean this could work for ...

A UCO team has applied the genome editing technique, which garnered a Nobel Prize in Chemistry in 2020, to unravel the ...